Literature DB >> 28248083

A Comprehensive Analytical Strategy To Identify Malondialdehyde-Modified Proteins and Peptides.

Juliane Weißer1, Claudia Ctortecka1, Clara J Busch1,2, Shane R Austin1,3, Karin Nowikovsky3, Koji Uchida4, Christoph J Binder1,2, Keiryn L Bennett1.   

Abstract

Mass spectrometric-based proteomics is a powerful tool to analyze post-translationally modified proteins. Carbonylation modifications that result from oxidative lipid breakdown are a class of post-translational modifications that are poorly characterized with respect to protein targets and function. This is partly due to the lack of dedicated mass spectrometry-based technologies to facilitate the analysis of these modifications. Here, we present a comprehensive approach to identify malondialdehyde-modified proteins and peptides. Malondialdehyde is among the most abundant of the lipid peroxidation products; and malondialdehyde-derived adducts on proteins have been implicated in cardiovascular diseases, neurodegenerative disorders, and other clinical conditions. Our integrated approach targets three levels of the overall proteomic workflow: (i) sample preparation, by employing a targeted enrichment strategy; (ii) high-performance liquid chromatography, by using a gradient optimized for the separation of the modified peptides; and (iii) tandem mass spectrometry, by improving the spectral quality of very low-abundance peptides. By applying the optimized procedure to a whole cell lysate spiked with a low amount of malondialdehyde-modified proteins, we were able to identify up to 350 different modified peptides and localize the modification to a specific lysine residue. This methodology allows the comprehensive analysis of malondialdehyde-modified proteins.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28248083     DOI: 10.1021/acs.analchem.6b05065

Source DB:  PubMed          Journal:  Anal Chem        ISSN: 0003-2700            Impact factor:   6.986


  2 in total

Review 1.  Dicarbonyls and Advanced Glycation End-Products in the Development of Diabetic Complications and Targets for Intervention.

Authors:  Sebastian Brings; Thomas Fleming; Marc Freichel; Martina U Muckenthaler; Stephan Herzig; Peter P Nawroth
Journal:  Int J Mol Sci       Date:  2017-05-05       Impact factor: 5.923

Review 2.  Irreversible oxidative post-translational modifications in heart disease.

Authors:  Tamara Tomin; Matthias Schittmayer; Sophie Honeder; Christoph Heininger; Ruth Birner-Gruenberger
Journal:  Expert Rev Proteomics       Date:  2019-07-30       Impact factor: 4.250

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.